Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRockwood Strat. Regulatory News (RKW)

Share Price Information for Rockwood Strat. (RKW)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 273.50
Bid: 273.00
Ask: 274.00
Change: -0.50 (-0.18%)
Spread: 1.00 (0.366%)
Open: 274.00
High: 274.00
Low: 273.50
Prev. Close: 274.00
RKW Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

27 Nov 2023 15:17

RNS Number : 8047U
Rockwood Strategic PLC
27 November 2023
 

Rockwood Strategic (RKW)

27/11/2023

Results analysis from Kepler Trust Intelligence

Rockwood Strategic (RKW) has released its results for the six month period ending 30/09/2023. The trust saw NAV and share price total returns of -5.5% and -2.5% respectively during the period, compared to equivalent returns of -10.3% in the FTSE AIM All Share Index and 2.9% in the FTSE Small Cap (Ex-ITs) Index.

That six month period captured a difficult period for UK small company shares which follows an exceptional fund track record over longer periods. In the 12 months to 30/09/2023, RKW delivered total returns for shareholders that were close to 30%. Since the period end and as at 22/11/2023, RKW was the top performer in the AIC's UK Small Cap sector over 1, 3, and 5 year periods. Annualised returns for that five year period were in excess of 20% on a share price total return basis.

This strong track record meant that RKW traded at a premium for much of the period, enabling the board to issue new equity to investors, expanding the shareholder base by 5.7%. We note that this is at a time when UK small caps and the wider investment trust sector have been massively out of favour, with average discounts for closed-ended funds at levels last seen during the financial crisis.

RKW Chairman Noel Lamb said: "The first half of our financial year has been a challenging one for UK small company stock market investors, with sustained outflows from the asset class amidst negative sentiment as interest rates continued to rise against a subdued economic backdrop. For those with sensible time horizons these are typically the conditions for positive future medium-term returns, not least due to the heavily depressed valuations of small company shares relative to history. Private Equity and Trade Buyers are clearly recognising the opportunities created by this environment with the drumbeat of takeovers within Rockwood's portfolio continuing throughout 2023."

Kepler View

Rockwood Strategic (RKW) takes a unique approach to the UK small cap sector, with manager Richard Staveley investing at the smallest end of the London Stock Exchange. He looks for companies that are undervalued and which have the potential to deliver a 15% IRR over a three to five year time frame. This process is helped by the fact that few other fund managers can invest in these companies, mainly due to size and liquidity constraints, and that they typically have little to no research coverage. RKW also takes an active approach with the firms it invests in, meaning members of the RKW team regularly taking up board positions with portfolio companies and push for change where needed. In the period Nick Mills from the investment team joined Trifast as a NED.

Three takeover bids in the RKW portfolio since the end of September are also a validation of the trust's investment process. These were all announced at substantial premiums to prior day closing prices, with Smoove acquired at a 69% premium, Onthemarket a 56% premium, and The Pub Group a 46% premium. We note that the prospective uplift for RKW was superior to each of these, given the entry point at which the managers invested.

RKW is also arguably well-positioned to continue its impressive track record moving forwards. The increasing level of M&A activity we are seeing in the portfolio and wider UK stock market is a sign that trade buyers and private equity firms clearly see the value these companies offer, even if other investors do not. At the same time, we think Richard's focus on valuations, cash flows, and strong balance sheets mean the RKW strategy can succeed, regardless of whether we are in a period in which rates have peaked or where they remain 'higher for longer'. Recent news that Downing Strategic Microcap (DSM) has plans to wind up means the trust is now one of the only closed-ended funds offering investors access to the UK's smallest companies.

CLICK HERE TO READ THE FULL REPORT  Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAEDLFLXFLFFBZ
Date   Source Headline
4th Sep 20234:27 pmRNSNet Asset Value(s)
1st Sep 20234:51 pmRNSNet Asset Value(s)
29th Aug 20233:31 pmRNSNet Asset Value(s)
21st Aug 20233:08 pmRNSNet Asset Value(s)
14th Aug 20234:31 pmRNSNet Asset Value(s)
7th Aug 20232:10 pmRNSNet Asset Value(s)
7th Aug 20237:00 amRNSIssue of Equity
1st Aug 20234:46 pmRNSNet Asset Value(s)
31st Jul 20234:02 pmRNSNet Asset Value(s)
24th Jul 20235:19 pmRNSNet Asset Value(s)
17th Jul 20235:27 pmRNSNet Asset Value(s)
10th Jul 20232:35 pmRNSNet Asset Value(s)
10th Jul 20237:00 amRNSIssue of Equity
7th Jul 20237:00 amRNSPosting of Annual Report and Notice of AGM
3rd Jul 20235:38 pmRNSNet Asset Value(s)
29th Jun 20237:00 amRNSDirector/PDMR Shareholding
28th Jun 20233:05 pmRNSIssue of Equity
26th Jun 20234:27 pmRNSNet Asset Value(s)
23rd Jun 20237:00 amRNSIssue of Equity
22nd Jun 20238:00 amRNSBlock listing Interim Review
22nd Jun 20237:00 amRNSFull Year Results to 31 March 2023
19th Jun 20235:19 pmRNSNet Asset Value(s)
12th Jun 20235:35 pmRNSNet Asset Value(s)
8th Jun 20237:00 amRNSIssue of Equity
7th Jun 20237:00 amRNSIssue of Equity
5th Jun 20234:04 pmRNSNet Asset Value(s)
2nd Jun 20237:00 amRNSIssue of Equity
1st Jun 20234:10 pmRNSNet Asset Value(s)
31st May 20237:00 amRNSInvestor Presentation via Investor Meet Company
30th May 20234:53 pmRNSNet Asset Value(s)
30th May 20238:45 amRNSIssue of Equity
24th May 20237:00 amRNSIssue of Equity
22nd May 20234:36 pmRNSNet Asset Value(s)
22nd May 20237:00 amRNSIssue of Equity
15th May 20233:50 pmRNSNet Asset Value(s)
9th May 20234:24 pmRNSNet Asset Value(s)
2nd May 20233:58 pmRNSNet Asset Value(s)
24th Apr 20233:50 pmRNSNet Asset Value(s)
17th Apr 20234:28 pmRNSNet Asset Value(s)
11th Apr 20235:16 pmRNSNet Asset Value(s)
11th Apr 20237:00 amRNSTrading Update
4th Apr 202311:46 amRNSNet Asset Value(s)
27th Mar 20234:13 pmRNSNet Asset Value(s)
24th Mar 20234:49 pmRNSQuotedData's Weekly News & Interview
22nd Mar 20232:29 pmRNSDirector Declaration
20th Mar 20233:52 pmRNSNet Asset Value(s)
13th Mar 20234:21 pmRNSNet Asset Value(s)
6th Mar 20234:46 pmRNSNet Asset Value(s)
1st Mar 20233:43 pmRNSNet Asset Value(s)
27th Feb 20235:16 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.